Composition
- Active ingredients
- EFAVIRENZ 600MG; LAMIVUDINE 300MG; TENOFOVIR DISOPROXIL FUMARATE 300MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA205861.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Efavirenz; Lamivudine; Tenofovir Disoproxil Fumarate
- Active substance
- efavirenz
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Macleods Pharms LTD
- Status
- Tentative approval
- FDA approval
- 14 Aug 2014
- Application
- NDA205861-001